Best of ACTHIV: Cardiovascular Risk Management in HIV

A nationally renowned researcher in the field of HIV and AIDS, Dr. Aberg has been instrumental in developing national, state, and local guidelines for HIV prevention and the care of HIV-infected persons. Her reputation as a scientific leader has been well established through her ongoing clinical research activities in HIV-related opportunistic infections, vaccine response, and complications of HIV disease, including studies of the pathogenesis of inflammation that contributes to the co-morbidities associated with the aging of those with HIV infection. Dr. Aberg serves as Chief of the Division of Infectious Diseases and Immunology and Director of the Infectious Diseases Clinical and Translational Research Center. Dr. Aberg serves on panels for the New York State Department of Health, the International AIDS Society-USA, and the Department of Health and Human Services. She was also Chair of the HIV Medicine Association (HIVMA), an organization representing more than 5,000 HIV providers advocating for policies to ensure a comprehensive response to the AIDS pandemic informed by science and social justice. She was recently elected as the HIVMA representative to the Infectious Disease Society of America’s Board of Directors. Dr. Aberg is the author of more than 100 peer-reviewed publications and has participated in more than 100 clinical trials. She is Co-Editor-in-Chief for HIV Clinical Trials, serves on the editorial board for two infectious disease journals, and is an ad hoc reviewer for more than 15 journals.